00000nam 2200000zi 4500 9.937142 CaOODSP 20240612114835 m o d f cr |n||||||||| 240419e20180620onc o f|0| 0 eng d CaOODSP eng rda CaOODSP n-cn--- H14-604/2018E-PDF Audit of the Biologics and Radiopharmaceutical Drugs Program at Health Canada, June 2018. [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, June 20, 2018. 1 online resource (27 unnumbered pages) + management response and action plan (5 unnumbered pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Audit du programme des produits biologiques et radiopharmaceutiques de Santé Canada, juin 2018. "Final report presented to the Departmental Audit Committee, June 20, 2018." "We examined the management control framework related to the Biologics and Radiopharmaceutical Drugs Program (BRDP or the Program). The audit focused on governance, risk management, and internal controls..."--Executive Summary, page [4]. Canada. Health Canada Auditing. Public Health Agency of Canada Auditing. Biologicals Canada Auditing. Canada. Health Canada, issuing body. Public Health Agency of Canada, issuing body. Audit du programme des produits biologiques et radiopharmaceutiques de Santé Canada, juin 2018. (CaOODSP)9.937144 PDF 603 KB https://publications.gc.ca/collections/collection_2024/sc-hc/H14-604-2018-eng.pdf Final report PDF 208 KB https://publications.gc.ca/collections/collection_2024/sc-hc/H14-604-2018-1-eng.pdf Management Response and Action Plan HTML N/A https://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/internal-audits/biologics-pharmaceutical-drugs-program.html Final report